| Статус: | Completed |
| Фаза: | N/A |
| Начало: | 23 марта 2021 г. |
| Окончание: | 30 августа 2022 г. |
| Описание: | Sepsis is a global healthcare burden sepsis, it reaches 20-30 million cases annually (WHO data). Numerous studies have shown that extracorporeal hemoperfusion therapies that eliminate endotoxin and\or excess of cytokines improve treatment outcomes in patients with septic shock. The main purpose of the study is to obtain new data on the efficacy and safety of the Efferon LPS device in extracorporeal therapy in patients with abdominal sepsis complicated by septic shock. |
| смотреть на ClinicalTrials.gov |